Leuprolide - wikidoc
One- and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate - ScienceDirect
Leuprolide Acetate | SpringerLink
Leuprorelin - Wikipedia
Mechanism of action of gonadotrophin-releasing hormone (GnRH) agonists... | Download Scientific Diagram
DRS
Oncology
Cardiovascular Safety of Degarelix Versus Leuprolide for Advanced Prostate Cancer: The PRONOUNCE Trial Study Design - ScienceDirect
Diagram of normal (A) and leuprolide acetate (LA)-modi®ed (B)... | Download Scientific Diagram
JCM | Free Full-Text | Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review | HTML
Degarelix: a novel gonadotropin-releasing hormone blocker for the treatment of prostate cancer | Future Oncology
Frontiers | Treatment of Breast Cancer With Gonadotropin-Releasing Hormone Analogs | Oncology
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer: Contemporary Meta-Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
The role of gonadotrophin-releasing hormone antagonists in the treatment of patients with advanced hormone-dependent prostate cancer in the UK | SpringerLink
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone | Nature Reviews Endocrinology
Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations | Prostate Cancer and Prostatic Diseases
Will GnRH antagonists improve prostate cancer treatment? - ScienceDirect
Abarelix for injectable suspension: first-in-class gonadotropin-releasing hormone antagonist for prostate cancer | Future Oncology
PDF) Leuprolide acetate: A drug of diverse clinical applications
Chemotherapy Options for Advanced Prostate Cancer - ppt download
Mechanism of action of gonadotrophin-releasing hormone (GnRH) agonists... | Download Scientific Diagram
FDA Approves Relugolix for Advanced Prostate Cancer - National Cancer Institute
GnHR Agonist or Lupron – Fibroid Treatment Collaborative
